| |
| |
|
| Insider
Information: |
Anderson Kenneth Carl |
| Relationship: |
Director |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
112,351 |
|
|
Indirect Shares
|
203,724 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
316,075 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
C4 Therapeutics, Inc. |
CCCC |
Director |
2024-04-01 |
112,351 |
2024-04-01 |
203,724 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2024-04-01 |
4 |
A |
$8.10 |
$11,251 |
D/D |
1,389 |
112,351 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2024-01-02 |
4 |
A |
$6.52 |
$11,247 |
D/D |
1,725 |
110,962 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2023-10-02 |
4 |
A |
$1.70 |
$11,249 |
D/D |
6,617 |
109,237 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2023-07-03 |
4 |
A |
$2.83 |
$11,252 |
D/D |
3,976 |
102,620 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2023-01-03 |
4 |
A |
$6.38 |
$10,004 |
D/D |
1,568 |
94,416 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2022-10-03 |
4 |
OE |
$2.11 |
$2,779 |
D/D |
712 |
91,698 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2022-10-03 |
4 |
A |
$8.69 |
$9,994 |
D/D |
1,150 |
92,848 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2022-07-15 |
4 |
OE |
$2.11 |
$5,556 |
D/D |
1,424 |
90,986 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2022-07-01 |
4 |
A |
$8.03 |
$10,005 |
D/D |
1,246 |
89,562 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2022-04-04 |
4 |
A |
$26.46 |
$9,023 |
D/D |
341 |
88,316 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2022-01-26 |
4 |
OE |
$2.11 |
$8,338 |
D/D |
2,137 |
87,975 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2022-01-04 |
4 |
A |
$31.58 |
$8,779 |
D/D |
278 |
85,838 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-10-04 |
4 |
A |
$44.99 |
$8,728 |
D/D |
194 |
85,560 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-07-02 |
4 |
A |
$39.72 |
$8,738 |
D/D |
220 |
85,366 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-04-14 |
4 |
OE |
$2.11 |
$2,774 |
D/D |
711 |
85,146 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-04-13 |
4 |
GA |
$0.00 |
$0 |
D/D |
2,278 |
84,435 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-04-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,278 |
47,316 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2021-01-22 |
4 |
OE |
$2.11 |
$5,818 |
D/D |
1,548 |
81,924 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
134,406 |
16,939 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
18,040 |
80,376 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
71,596 |
|
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
62,336 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
